Permeabilization of the Blood-Brain Barrier via Mucosal Engrafting: Implications for Drug Delivery to the Brain

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Bleier, Benjamin S ^a   Kohman, Richie E ^b   Feldman, Rachel E ^a   Ramanlal, Shreshtha ^b   Han, Xue ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Boston University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN; RHODAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOTRANSPLANTATION; BLOOD BRAIN BARRIER; CONTROLLED STUDY; CORPUS STRIATUM; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; ENDOSCOPIC SURGERY; MEMBRANE PERMEABILITY; MOLECULAR WEIGHT; MOUSE; MUCOSAL ENGRAFTING; NEUROPHARMACOLOGY; NONHUMAN; NOSE MUCOSA; PARKINSON DISEASE; SKULL SURGERY; TISSUE TRANSPLANTATION;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; CORPUS STRIATUM; DEXTRANS; DIFFUSION; MICE; MOLECULAR WEIGHT; NASAL MUCOSA; PERMEABILITY; RHODAMINES; TIME FACTORS;

MURINAE;

EID: 84876521577     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061694     Document Type: Article

References (22)

1. Shoichet MS, Winn SR, (2000) Cell delivery to the central nervous system. Adv Drug Deliv Rev. 42: 81-102.
2. Ngwuluka N, Pillay V, Du Toit LC, Ndesendo V, Choonara Y, et al. (2010) Levodopa delivery systems: advancements in delivery of the gold standard. Expert Opin Drug Deliv. 7: 203-24.
3. Cardoso FL, Brites D, Brito MA, (2010) Looking at the blood-brain barrier: molecular anatomy and possible investigation approaches. Brain Res Rev. 64: 328-63.
4. Nutt JG, Burchiel KJ, Comella CL, Jankovic J, Lang AE, et al. (2003) Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology. 60: 69-73.
5. Zhao HM, Liu XF, Mao XW, Chen CF, (2004) Intranasal delivery of nerve growth factor to protect the central nervous system against acute cerebral infarction. Chin Med Sci J. 19: 257-61.
6. Fisher AN, Illum L, Davis SS, Schacht EH, (1992) Di-iodo-L-tyrosine-labelled dextrans as molecular size markers of nasal absorption in the rat. J Pharm Pharmacol. 44: 550-4.
7. Merkus FW, van den Berg MP, (2007) Can nasal drug delivery bypass the blood-brain barrier?: Questioning the direct transport theory. Drugs R D. 8: 133-44.
8. Bleier BS, Wang EW, Vandergrift WA, Schlosser RJ, (2011) Mucocele Rate Following Endoscopic Skull Base Reconstruction Using Vascularized Pedicled Flaps. Am J Rhinol Allergy. 25: 186-7.
9. Bernal-Sprekelsen M, Alobid I, Mullol J, Trobat F, Tomás-Barberán M, (2005) Closure of cerebrospinal fluid leaks prevents ascending bacterial meningitis. Rhinology. 43: 277-81.
10. Dietz GP, Valbuena PC, Dietz B, Meuer K, Müeller P, et al. (2006) Application of a blood-brain-barrier-penetrating form of GDNF in a mouse model for Parkinson's disease. Brain Res. 1082: 61-6.
11. Gill SS, Patel NK, Hotton GR, O'Sullivan K, McCarter R, et al. (2003) Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med. 9: 589-95.
12. Dewey Jr RB, Maraganore DM, Ahlskog JE, Matsumoto JY, (1998) A double-blind, placebo-controlled study of intranasal apomorphine spray as a rescue agent for off-states in Parkinson's disease. Mov Disord. 13: 782-7.
13. Illum L, (2003) Nasal drug delivery-possibilities, problems and solutions. J Control Release. 87: 187-98.
14. Bagger MA, Bechgaard E, (2004) The potential of nasal application for delivery to the central brain-a microdialysis study of fluorescein in rats. Eur J Pharm Sci. 21: 235-42.
15. Bleier BS, Debnath I, Harvey RJ, Schlosser RJ, (2011) Temporospatial quantification of fluorescein-labeled sinonasal irrigation delivery. Int Forum Allergy Rhinol. 1: 361-5.
16. Dhuria SV, Hanson LR, Frey WH 2nd (2010) Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci. 99: 1654-73.
17. Bleier BS, Palmer JN, Sparano AM, Cohen NA, (2007) Laser-assisted cerebrospinal fluid leak repair: an animal model to test feasibility. Otolaryngol Head Neck Surg. 137: 810-4.
18. Nance EA, Woodworth GF, Sailor KA, Shih TY, Xu Q, et al. (2012) A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue. Sci Transl Med. 4: 149ra119.
19. Bleier BS, Kofonow JM, Hashmi N, Chennupati SK, Cohen NA, (2010) Antibiotic eluting chitosan glycerophosphate implant in the setting of acute bacterial sinusitis: a rabbit model. Am J Rhinol Allergy. 24: 129-32.
20. Modi G, Pillay V, Choonara YE, (2010) Advances in the treatment of neurodegenerative disorders employing nanotechnology. Ann N Y Acad Sci. 1184: 154-72.
21. Antunes MB, Woodworth BA, Bhargave G, Xiong G, Aguilar JL, et al. (2007) Murine nasal septa for respiratory epithelial air-liquid interface cultures. Biotechniques. 43: 195-6.
22. Kirkeby S, Thomsen CE, (2005) Quantitative immunohistochemistry of fluorescence labeled probes using low-cost software. J Immunol Methods. 301: 102-13.